VOR

Vor Biopharma Names Matthew R. Patterson as Chairman and Promotes Tania Philipp

Vor Biopharma to Present at Jefferies and Goldman Sachs Investor Conferences

Vor Reports Fiscal Year 2020 Financial Results

Vor Biopharma to Present at the Barclays Global Healthcare Conference

Vor Biopharma Announces Participation at Cowen 41st Annual Health Care Conference

Vor Biopharma Closes Over $200M Initial Public Offering, Including Full Exercise of Option to Purchase Additional Shares

VOR Stock Price Increased 108.33%: Why It Happened